2021, Vol. 4, Issue 1, Part A
Assessment of supraclavicular brachial plexus block with or without dexamethasone as an adjuvant to 0.5% levobupivacaine
Author(s): Dr. Sherley S Cherian, Dr. Shailesh Kumar, Dr. Juma Jaleel and Dr. Brijesh GC
Abstract: Background: Brachial plexus block is an excellent method for attaining optimal operating conditions for upper limb surgeries by producing complete muscular relaxation, maintaining haemodynamic stability and the associated sympathetic block. The present study was conducted to assess supraclavicular brachial plexus block with or without dexamethasone as an adjuvant to 0.5% levobupivacaine.
Materials and methods: 50 patients of 18-60 years were allocated in two groups of 25 each. In group I, patients received 30 ml of 0.5% isobaric levobupivacaine with 2 ml of isotonic sodium chloride. In group II patients received 8mg (2ml) dexamethasone in addition to 30ml of 0.5% isobaric levobupivacaine.
Results: Group I had 15 males and 10 females and group II had 12 males and 13 females. The mean duration of surgery was 62.4 minutes in group I and 63.2 minutes in group II, onset of sensory blockade was 10.4 minutes in group I and 8.1 minutes in group II, onset of motor blockade was 15.4 minutes and 13.2 minutes, duration of sensory blockade was 658.2 minutes and 925.6 minutes, duration of motor blockade was 572.4 minutes and 764.2 minutes and total analgesic requirement was 22 and 1 in in group I and in group II respectively. The difference was significant (P< 0.05).
Conclusion: Dexamethasone found to reduce the time to onset of sensory and motor blockage and prolongs the duration of analgesia.
DOI: 10.33545/26643766.2021.v4.i1a.191
Pages: 25-27 | Views: 1267 | Downloads: 627
Download Full Article: Click Here
How to cite this article:
Dr. Sherley S Cherian, Dr. Shailesh Kumar, Dr. Juma Jaleel, Dr. Brijesh GC. Assessment of supraclavicular brachial plexus block with or without dexamethasone as an adjuvant to 0.5% levobupivacaine. Int J Med Anesthesiology 2021;4(1):25-27. DOI: 10.33545/26643766.2021.v4.i1a.191
